TABLE OF CONTENTS
| | | | Volume 20, Issue 9 (September 2012) | | In this issue Editorial In This Issue Research Highlights Letter to the Editor Commentaries Original Articles Abstracts
Also new AOP
| | | | | Advertisement | | | | | Editorial | Top | | Differing Approaches to Experimental Therapeutics: Are We a World Apart?Timothy P Cripe Mol Ther 2012 20: 1649-1650; 10.1038/mt.2012.174 Full Text | | In This Issue | Top | | In This IssueMol Ther 2012 20: 1652; 10.1038/mt.2012.176 Full Text | | Research Highlights | Top | | Research HighlightsMol Ther 2012 20: 1653; 10.1038/mt.2012.177 Full Text | | Letter to the Editor | Top | | Treatment of Chemotherapy-Refractory Cancer in the Advanced Therapy Access ProgramAkseli Hemminki Mol Ther 2012 20: 1654-1655; 10.1038/mt.2012.170 Full Text | | Commentaries | Top | | Athletes’ Use of Unproven Stem Cell Therapies: Adding to Inappropriate Media Hype?Timothy Caulfield and Amy McGuire Mol Ther 2012 20: 1656-1658; 10.1038/mt.2012.172 Full Text | | | | A CRISPR Approach to Gene TargetingDana Carroll Mol Ther 2012 20: 1658-1660; 10.1038/mt.2012.171 Full Text | | | | All for One, One for All: New Combinatorial RNAi Therapies Combat Hepatitis C Virus EvolutionDirk Grimm Mol Ther 2012 20: 1661-1663; 10.1038/mt.2012.173 Full Text | | Original Articles | Top | | Immunotherapeutic Synergy Between Anti-CD137 mAb and Intratumoral Administration of a Cytopathic Semliki Forest Virus Encoding IL-12José I Quetglas, Juan Dubrot, Jaione Bezunartea, Miguel F Sanmamed, Sandra Hervas-Stubbs, Cristian Smerdou and Ignacio Melero Mol Ther 2012 20: 1664-1675; advance online publication, June 26, 2012; 10.1038/mt.2012.56 Abstract | Full Text | | | | Failure of Translation of Human Adenovirus mRNA in Murine Cancer Cells Can be Partially Overcome by L4-100K Expression In Vitro and In VivoAnna-Mary Young, Kyra M Archibald, Laura A Tookman, Alexander Pool, Kate Dudek, Carolyn Jones, Sarah L Williams, Katrina J Pirlo, Anne E Willis, Michelle Lockley and Iain A McNeish Mol Ther 2012 20: 1676-1688; advance online publication, June 26, 2012; 10.1038/mt.2012.116 Abstract | Full Text | | | | Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene ExpressionOmar D Perez, Christopher R Logg, Kei Hiraoka, Oscar Diago, Ryan Burnett, Akihito Inagaki, Dawn Jolson, Karin Amundson, Taylor Buckley, Dan Lohse, Amy Lin, Cindy Burrascano, Carlos Ibanez, Noriyuki Kasahara, Harry E Gruber and Douglas J Jolly Mol Ther 2012 20: 1689-1698; advance online publication, May 1, 2012; 10.1038/mt.2012.83 Abstract | Full Text | | | | Lentiviral Vectors Displaying Modified Measles Virus gp Overcome Pre-existing Immunity in In Vivo-like Transduction of Human T and B CellsCamille Lévy, Fouzia Amirache, Caroline Costa, Cecilia Frecha, Claude P Muller, Hasan Kweder, Robin Buckland, François-Loïc Cosset and Els Verhoeyen Mol Ther 2012 20: 1699-1712; advance online publication, May 22, 2012; 10.1038/mt.2012.96 Abstract | Full Text | | | | Gene Transfer to the CNS Is Efficacious in Immune-primed Mice Harboring Physiologically Relevant Titers of Anti-AAV AntibodiesChristopher M Treleaven, Thomas J Tamsett, Jie Bu, Jonathan A Fidler, S Pablo Sardi, Gregory D Hurlbut, Lisa A Woodworth, Seng H Cheng, Marco A Passini, Lamya S Shihabuddin and James C Dodge Mol Ther 2012 20: 1713-1723; advance online publication, June 26, 2012; 10.1038/mt.2012.114 Abstract | Full Text | | | | Inhibition of Hepatitis C Virus Replication by Intracellular Delivery of Multiple siRNAs by NanosomesPartha K Chandra, Anup K Kundu, Sidhartha Hazari, Sruti Chandra, Lili Bao, Tara Ooms, Gilbert F Morris, Tong Wu, Tarun K Mandal and Srikanta Dash Mol Ther 2012 20: 1724-1736; advance online publication, May 22, 2012; 10.1038/mt.2012.107 Abstract | Full Text | | | | Safe, Long-term Hepatic Expression of Anti-HCV shRNA in a Nonhuman Primate ModelDavid A Suhy, Shih-Chu Kao, Tin Mao, Laurence Whiteley, Hubert Denise, Bernard Souberbielle, Andrew D Burdick, Kyle Hayes, J Fraser Wright, Helen Lavender, Peter Roelvink, Alexander Kolykhalov, Kevin Brady, Sterghios A Moschos, Bernd Hauck, Olga Zelenaia, Shangzhen Zhou, Curt Scribner, Katherine A High, Sara H Renison and Romu Corbau Mol Ther 2012 20: 1737-1749; advance online publication, June 26, 2012; 10.1038/mt.2012.119 Abstract | Full Text | | | | Secondary Sphere Formation Enhances the Functionality of Cardiac Progenitor CellsHyun-Jai Cho, Ho-Jae Lee, Seock-Won Youn, Seok-Jin Koh, Joo-Yun Won, Yeon-Ju Chung, Hyun-Ju Cho, Chang-Hwan Yoon, Sae-Won Lee, Eun Ju Lee, Yoo-Wook Kwon, Hae-Young Lee, Sang Hun Lee, Won-Kyung Ho, Young-Bae Park and Hyo-Soo Kim Mol Ther 2012 20: 1750-1766; advance online publication, June 19, 2012; 10.1038/mt.2012.109 Abstract | Full Text | | | | Inducible IL10+ Suppressor B Cells Inhibit CNS Inflammation and T Helper 17 PolarizationJeremy Hsieh, Patrick Williams, Moutih Rafei, Elena Birman, Jessica Cuerquis, Shala Yuan, JianHui Wu and Jacques Galipeau Mol Ther 2012 20: 1767-1777; advance online publication, July 3, 2012; 10.1038/mt.2012.127 Abstract | Full Text | | | | Enforced IL-10 Expression Confers Type 1 Regulatory T Cell (Tr1) Phenotype and Function to Human CD4+ T CellsGrazia Andolfi, Georgia Fousteri, Maura Rossetti, Chiara F Magnani, Tatiana Jofra, Grazia Locafaro, Attilio Bondanza, Silvia Gregori and Maria-Grazia Roncarolo Mol Ther 2012 20: 1778-1790; advance online publication, June 12, 2012; 10.1038/mt.2012.71 Abstract | Full Text | | | | Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell VaccineChantal G Lemay, Julia L Rintoul, Agnieszka Kus, Jennifer M Paterson, Vanessa Garcia, Theresa J Falls, Lisa Ferreira, Byram W Bridle, David P Conrad, Vera A Tang, Jean-Simon Diallo, Rozanne Arulanandam, Fabrice Le Boeuf, Kenneth Garson, Barbara C Vanderhyden, David F Stojdl, Brian D Lichty, Harold L Atkins, Kelley A Parato, John C Bell and Rebecca C Auer Mol Ther 2012 20: 1791-1799; advance online publication, July 3, 2012; 10.1038/mt.2012.128 Abstract | Full Text | | | | PD-1/PD-L1 Blockade Can Enhance HIV-1 Gag-specific T Cell Immunity Elicited by Dendritic Cell-Directed Lentiviral VaccinesBingbing Dai, Liang Xiao, Paul D Bryson, Jinxu Fang and Pin Wang Mol Ther 2012 20: 1800-1809; advance online publication, May 15, 2012; 10.1038/mt.2012.98 Abstract | Full Text | | | | HSV-1 Amplicon Vectors Launch the Production of Heterologous Rotavirus-like Particles and Induce Rotavirus-specific Immune Responses in MiceAndrea S Laimbacher, Laura E Esteban, Alejandro A Castello, Juan C Abdusetir Cerfoglio, Marcelo H Argüelles, Graciela Glikmann, Alejandra D'Antuono, Nora Mattion, Mabel Berois, Juan Arbiza, Monika Hilbe, Elisabeth M Schraner, Michael Seyffert, Christiane Dresch, Alberto L Epstein, Mathias Ackermann and Cornel Fraefel Mol Ther 2012 20: 1810-1820; advance online publication, June 19, 2012; 10.1038/mt.2012.108 Abstract | Full Text | | | | Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory CancerOtto Hemminki, Iulia Diaconu, Vincenzo Cerullo, Saila K Pesonen, Anna Kanerva, Timo Joensuu, Kalevi Kairemo, Leena Laasonen, Kaarina Partanen, Lotta Kangasniemi, Andre Lieber, Sari Pesonen and Akseli Hemminki Mol Ther 2012 20: 1821-1830; advance online publication, August 7, 2012; 10.1038/mt.2012.115 Abstract | Full Text | | Abstracts | Top | | Late Abstracts: Presented at the American Society of Gene & Cell Therapy’s 15th Annual Meeting, May 16–19, 2012, Philadelphia, PennsylvaniaMol Ther 2012 20: e1-e63; 10.1038/mt.2012.179 Full Text | | | | Molecular Therapy-Nucleic Acids Online.Open Access.High-Quality Research. Molecular Therapy-Nucleic Acids is a peer-reviewed, fully open access, online journal. Sibling journal to the well-established high impact journal, Molecular Therapy. The journal publishes high quality basic, translational, and clinical research and cutting edge reviews and commentaries targeted to the advances in oligonucleotide- and gene-based therapies. Submit your research TODAY!! | | | | Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Molecular Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. | | | | |
No comments:
Post a Comment